Dr. Cecilia Yeung on the utility of Anchored Multiplex PCR for gene fusion detection

Published Thu Oct 11, 2018


In this talk, Dr. Cecilia Yeung from the Fred Hutchinson Cancer Research Center discusses her experience using Anchored Multiplex PCR (AMP™) technology to identify fusions in leukemias. Dr. Yeung and her team used Archer® FusionPlex® assays to sequence myeloid and Acute Lymphoma Leukemia (ALL) samples. They were able to successfully detect point mutations, small indels and expression data using the Archer Analysis bioinformatics platform. Additionally, Dr. Yeung used the RNA-based Archer assay in conjunction with a MinION® real-time sequencer (Oxford Nanopore Technologies) for rapid fusion detection. Watch the video to find out the results.

This video was recorded at the Cancer Genomics Consortium (CGC) annual meeting in August, 2018.

Utility of Anchored Multiplex PCR for gene fusion detection

 

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2018 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.